NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT00828412,Comparison of the Efficacy and Safety of Two Topical Creams for Pediatric Atopic Dermatitis,https://clinicaltrials.gov/study/NCT00828412,,COMPLETED,This study compares the effectiveness of two topical creams for atopic dermatitis in pediatric subjects. Subjects will be randomly assigned to use one of the two creams twice daily for 6 weeks or until clear.,YES,Atopic Dermatitis,DEVICE: EpiCeram Skin Barrier Emulsion|DRUG: Desonide Cream 0.05%,"Change From Baseline in Three Item Severity Score, The average of the sum of scores for erythema, edema/papulation, and excoriation for two target lesions. Scoring on a scale of 0 to 3 (none to severe). Maximum score is 9., Baseline to 6 weeks",,,"Promius Pharma, LLC",,ALL,CHILD,PHASE4,100,INDUSTRY,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (INVESTIGATOR)|Primary Purpose: TREATMENT,EPC0801,2009-03,2009-08,2009-08,2009-01-26,2013-09-17,2017-01-30,"National Jewish Health, Denver, Colorado, 80206, United States|Northwestern University, Chicago, Illinois, 60611, United States|Wake Forest University Health Sciences, Winston Salem, North Carolina, 27157, United States|Dermatology Research Associates, Cincinnati, Ohio, 45230, United States|University of Texas, Houston, Texas, 77030, United States",
